| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,065,587 ) |
| | 2025 | 2025 | REJUVENATION TECHNOLOGIES INC. | 415 CLYDE AVE | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44TR005328 | Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic | 000 | 2 | NIH | 4/28/2025 | $1,065,587 |
|
| Issue Date FY: 2024 ( Subtotal = $3,267,298 ) |
| | 2024 | 2024 | REJUVENATION TECHNOLOGIES INC. | 415 CLYDE AVE | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44AA028749 | TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis | 000 | 3 | NIH | 7/26/2024 | $1,858,106 |
| | 2024 | 2024 | REJUVENATION TECHNOLOGIES INC. | 415 CLYDE AVE | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44TR005328 | Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic | 000 | 1 | NIH | 7/26/2024 | $1,084,194 |
| | 2024 | 2024 | REJUVENATION TECHNOLOGIES INC. | 415 CLYDE AVE | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R43GM153144 | Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells | 000 | 1 | NIH | 9/4/2024 | $324,998 |
| | 2024 | 2022 | REJUVENATION TECHNOLOGIES INC. | 415 CLYDE AVE | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44HL166034 | TERT mRNA lipid nanoparticles to extend telomeres to treat pulmonary fibrosis | 000 | 1 | NIH | 2/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $626,743 ) |
| | 2023 | 2023 | REJUVENATION TECHNOLOGIES INC | 415 CLYDE AVE UNIT 107 | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44AA028749 | TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis | 000 | 2 | NIH | 9/20/2023 | $626,743 |
|
| Issue Date FY: 2022 ( Subtotal = $299,987 ) |
| | 2022 | 2022 | REJUVENATION TECHNOLOGIES INC | 415 CLYDE AVE UNIT 107 | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R44HL166034 | TERT mRNA lipid nanoparticles to extend telomeres to treat pulmonary fibrosis | 000 | 1 | NIH | 9/22/2022 | $299,987 |
| | 2022 | 2020 | REJUVENATION TECHNOLOGIES INC | 415 CLYDE AVE UNIT 107 | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R41AA028749 | Preventing liver fibrosis in alcoholic hepatitis by enhancing liver regenerative capacity via transient telomere extension using lipid nanoparticle-encapsulated TERT mRNA | 000 | 1 | NIH | 3/29/2022 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $272,403 ) |
| | 2020 | 2020 | REJUVENATION TECHNOLOGIES INC | 415 CLYDE AVE UNIT 107 | MOUNTAIN VIEW | CA | 94043-2230 | SANTA CLARA | USA | R41AA028749 | Preventing liver fibrosis in alcoholic hepatitis by enhancing liver regenerative capacity via transient telomere extension using lipid nanoparticle-encapsulated TERT mRNA | 000 | 1 | NIH | 9/4/2020 | $272,403 |
|
|
